EUVIMEDEUVIMED entdecken
Crossref

Frailty Burden and Efficacy of Initial Invasive Strategy in Chronic Coronary Disease: The ISCHEMIA Trials

Lajjaben Patel iD, Matthew W Segar iD, Muhammad S Usman iD, Ritika Dhruve iD, Neil Keshvani iD, Alexander Postalian iD, Amgad Mentias iD, Craig D Rubin iD, Kershaw V Patel iD, Dharam J Kumbhani iD, Subhash Banerjee iD, Ambarish Pandey iD

Journal of the American Geriatrics Society · 2025

DOI: 10.1111/jgs.19508 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Geriatrics Society, 2025. Verfasst von Lajjaben Patel und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Department of Medicine, UT Southwestern Medical Center, Dallas, Texas, USA. Hauptthemen laut MEDLINE: Frailty, Coronary Disease. Die Arbeit nennt 46 Literaturangaben. Gefördert von: Gilead Sciences Research Scholar Program, Texas Health Resources Clinical Scholarship, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Frailty is common among patients with chronic coronary disease and is associated with worse outcomes.

Methods

A pooled, post hoc analysis of the ISCHEMIA and ISCHEMIA‐CKD trials was conducted. Baseline frailty was assessed using a Frailty Index (FI), and participants were categorized into data‐derived tertiles. Multivariable Cox models with multiplicative interaction terms (frailty × treatment arm) were constructed to evaluate whether baseline frailty status modified the treatment effect of the initial invasive (vs conservative) strategy on a composite outcome of cardiovascular death, myocardial infarction, hospitalization for unstable angina, heart failure, or resuscitated cardiac arrest and the secondary outcome of HRQoL (Seattle Angina Questionnaire [SAQ]).

Results

Among 5322 participants (mean 64 years, 24% female), a high frailty burden (tertile 3 vs. tertile 1) was associated with lower baseline SAQ scores and increased risk of adverse clinical outcomes on follow‐up. Baseline frailty burden did not significantly modify the effect of the initial invasive strategy on the primary composite outcome ( P interaction frailty × intervention arm = 0.30). However, frailty significantly modified the effect of the initial invasive strategy on HRQoL, with higher baseline frailty burden associated with greater improvement in SAQ scores at 1 year with initial invasive (vs. conservative) treatment ( P interaction frailty × intervention arm < 0.001). The treatment effect of an initial invasive vs. conservative strategy on 12‐month SAQ score change was most pronounced in individuals with lower baseline SAQ scores in both higher and lower frailty burden groups.

Conclusion

Patients with chronic coronary disease with a higher frailty burden are more likely to experience greater improvements in HRQoL with initial invasive management without a higher risk of adverse clinical events. Lower baseline SAQ scores predicted greater improvement in HRQoL with initial invasive management, independent of frailty burden.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FrailtyCoronary DiseaseHumansFemaleMaleMiddle AgedAgedChronic DiseaseQuality of LifeTreatment Outcome

Stichwörter der Autor:innen

chronic coronary diseasefrailtyinvasive treatmentquality of life

Autor:innen und Institutionen

  • Division of Cardiology, Department of Medicine, UT Southwestern Medical Center, Dallas, Texas, USA.
  • Division of Cardiology, Texas Heart Institute, Houston, Texas, USA.
  • Department of Cardiology, Cleveland Clinic, Cleveland, Ohio, USA.
  • Division of Geriatric Medicine, Department of Medicine, UT Southwestern Medical Center, Dallas, Texas, USA.
  • Department of Cardiology, Houston Methodist DeBakey Heart and Vascular Center, Houston, Texas, USA.
  • Baylor University Medical Center, Dallas, Texas, USA.

ORCID-Profile: Lajjaben Patel, Matthew W Segar, Muhammad S Usman, Ritika Dhruve, Neil Keshvani, Alexander Postalian, Amgad Mentias, Craig D Rubin, Kershaw V Patel, Dharam J Kumbhani, Subhash Banerjee, Ambarish Pandey

Förderung

  • Gilead Sciences Research Scholar Program
  • Texas Health Resources Clinical Scholarship
  • NHLBI NIH HHS
  • American Heart Association
  • Myovista Research
  • NIMHD NIH HHS
  • NIA NIH HHS
  • Applied Therapeutics

Zitieren

APA

Patel, L., Segar, M. W., Usman, M. S., Dhruve, R., Keshvani, N., Postalian, A., Mentias, A., Rubin, C. D., Patel, K. V., Kumbhani, D. J., Banerjee, S., & Pandey, A. (2025). Frailty Burden and Efficacy of Initial Invasive Strategy in Chronic Coronary Disease: The ISCHEMIA Trials. Journal of the American Geriatrics Society. https://doi.org/10.1111/jgs.19508

Vancouver

Patel L, Segar MW, Usman MS, Dhruve R, Keshvani N, Postalian A, et al. Frailty Burden and Efficacy of Initial Invasive Strategy in Chronic Coronary Disease: The ISCHEMIA Trials. Journal of the American Geriatrics Society. 2025. doi:10.1111/jgs.19508

BibTeX
@article{Patel2025,
  author = {Patel, Lajjaben and Segar, Matthew W and Usman, Muhammad S and Dhruve, Ritika and Keshvani, Neil and Postalian, Alexander and Mentias, Amgad and Rubin, Craig D and Patel, Kershaw V and Kumbhani, Dharam J and Banerjee, Subhash and Pandey, Ambarish},
  title = {Frailty Burden and Efficacy of Initial Invasive Strategy in Chronic Coronary Disease: The ISCHEMIA Trials},
  journal = {Journal of the American Geriatrics Society},
  year = {2025},
  doi = {10.1111/jgs.19508}
}
Kostenlos starten →